Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
February 2013 Volume 29 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February 2013 Volume 29 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Early growth response 1 regulates glucose deprivation-induced necrosis

  • Authors:
    • Hyun Min Jeon
    • Su Yeon Lee
    • Min Kyung Ju
    • Cho Hee Kim
    • Hye Gyeong Park
    • Ho Sung Kang
  • View Affiliations / Copyright

    Affiliations: Department of Molecular Biology, College of Natural Sciences, Pusan National University, Pusan 609-735, Republic of Korea, Nanobiotechnology Center, Pusan National University, Pusan 609-735, Republic of Korea
  • Pages: 669-675
    |
    Published online on: November 14, 2012
       https://doi.org/10.3892/or.2012.2134
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Necrosis is commonly found in the core region of solid tumours due to metabolic stress such as hypoxia and glucose deprivation (GD) resulting from insufficient vascularization. Necrosis promotes tumour growth and development by releasing the tumour-promoting cytokine high mobility group box 1 (HMGB1); however, the molecular mechanism underlying necrotic cell death remains largely unknown. In this study, we show that early growth response 1 (Egr-1) is induced in a reactive oxygen species (ROS)-dependent manner by GD in several cell lines such as A549, MDA-MB-231 and HepG2 cells that exhibit necrosis upon GD. We found that Egr-1 short hairpin RNA (shRNA) prevented GD-induced necrosis and HMGB1 release. Necrosis-inhibiting activity of Egr-1 shRNA was also seen in multicellular tumour spheroids (MTSs), an in vitro tumour model system. In contrast, Egr-1 overexpression appeared to make tumour cells more susceptible to GD-induced necrosis. Finally, Egr-1 shRNA suppressed the growth of MTSs. These findings demonstrate that Egr-1 is implicated in GD-induced necrosis and tumour progression.

Introduction

Unlike tumour suppressive apoptosis and autophagic cell death, necrosis promotes tumour growth, progression, and aggressiveness (1,2). The tumour promoting activity of necrosis is thought to be mediated by a nuclear protein high mobility group box 1 (HMGB1), which exerts pro-inflammatory and tumour-promoting cytokine activities when released into the extracellular spaces due to the rupture of the plasma membrane by necrosis (1–4). In solid tumours, the cells in the inner regions experience metabolic stress such as hypoxia and glucose deprivation (GD) resulting from insufficient vascularization. Although most cells adapt to this environment to obtain more aggressive properties, those in the core region die by necrosis, thereby forming the necrotic core (5). Because necrosis is linked to tumour growth and development, it is an important cell death type in tumour cell biology; however, the molecular mechanism underlying necrotic cell death remains largely unknown.

Early growth response 1 (Egr-1) is a 3 Cys2-His2 type COOH-terminal zinc-finger transcription factor that binds to GC-rich recognition motifs (5′-GCGT/GGGGCG-3′ or 5′-TCCT/ACCTCCTCC-3′) (6,7). Egr-1 is induced by a number of different stimuli, such as anti-cancer drugs and growth factors and inhibits or stimulates tumour growth depending the cellular context and the duration of Egr-1 induction (6–13). Egr-1 was able to directly regulate multiple tumour suppressors including p53, TGF-β1, and PTEN to induce apoptotic cell death (14). In addition, Egr-1 is induced by hypoxia and plays a critical role(s) in hypoxia-induced tumour progression, survival, and angiogenesis (15–18). Furthermore, Egr-1 is involved in hepatocyte growth factor (HGF)-induced cell scattering, migration, and invasion via Snail activation (19). While transient induction of Egr-1 is known to activate angiogenesis, sustained Egr-1 expression induces antiangiogenesis, growth arrest, and apoptosis (20). Thus, Egr-1 is thought to act as a crucial regulator of tumour cell death, growth, invasion, and angiogenesis.

In this study, we tried to identify the mechanism underlying metabolic stress-induced necrosis. Previously, we showed that GD induced necrosis in several tumour cell types including A549, MDA-MB-231, and HepG2 cells and activation of protein kinase C by treatment of phorbol 12-myristate 13-acetate (PMA) switched GD-induced necrosis to apoptosis in A549 cells (21). By cDNA microarray analysis, we found that Egr-1 expression was increased by GD, but not by GD+PMA. In this study, we evaluated the possible role(s) of Egr-1 in necrosis. We found that Egr-1 shRNA prevented necrosis, whereas Egr-1 overexpression made tumour cells more sensitive to GD, thereby leading to necrosis. In addition, Egr-1 shRNA suppressed the growth of multicellular tumour spheroids (MTSs), an in vitro tumour model system. Taken together, these results demonstrate that Egr-1 plays an important role(s) in GD-induced necrosis and tumour progression.

Materials and methods

Cell culture, chemical treatment, and multicellular tumour spheroid (MTS) culture

A549, MDA-MB-231, HepG2, HCT116, and HeLa cells were obtained from American Type Culture Collection, and maintained in RPMI-1640 or DMEM supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Hyclone, Logan, UT, USA) and 1% penicillin-streptomycin (Hyclone) in a 37°C humidified incubator with 5% CO2. The cells were treated with GD, reactive oxygen species [ROS, including H2O2 and menadione (an O2- generator)], or other chemicals as described previously (22). Multicellular tumour spheroid culture was performed using MCF-7 cells (provided by Dr J.I. Yook, University of Yonsei, Korea) as described previously (22) and MTSs dissociation into subpopulations of cells from four different locations was conducted as described by LaRue and colleagues (23).

Microarray

Microarray was performed to screen the differentially expressed genes using Operon Human Whole 35K Oligo chips (GenoCheck, Korea) (22). The Affymetrix microarray data have been deposited in the Gene Expression Omnibus (GEO) database (GEO accession no. GSE24271).

Western blotting, HMGB1 release assay, RT-PCR, and real-time PCR

Western blotting were performed using the following antibodies: Egr-1 (Santa Cruz, CA); α-tubulin (Biogenex, CA); HMGB1 (BD Pharmingen, CA); CuZnSOD (Santa Cruz, CA); ERK1/2 (Cell Signaling, MA). The HMGB1 release assay was carried out as described previously (21,22). Transcript levels were assessed with reverse transcription-polymerase chain reaction (RT-PCR) with primers for Egr-1 and GAPDH (Table I). Quantitative real-time PCR was conducted in a LightCycler (Roche Diagnostics, Mannheim, Germany) using a SYBR Green kit (Roche Diagnostics) with primers for Egr-1 and β-actin (Table I).

Table I

Sequences used in this study for RT-PCR, real-time PCR, and shRNA interference.

Table I

Sequences used in this study for RT-PCR, real-time PCR, and shRNA interference.

Sequence 5′→3′Annealing temperature (°C)
RT-PCR
 GAPDH
  NM_002046.3Sense GTGGTCTCCTCTGACTTCAAC
Antisense TCTCTTCCTCTTGTGCTCTTG
Egr-1
 NM_001964.2Sense ATTCTGAGGCCTCGCAAGTA54
Antisense CACTGCTTTTCCGCTCTTTC
Real-time PCR
 β-actin
  NM_001101.3Sense ACTCTTCCAGCCTTCCTTCC
Antisense TGTTGGCGTACAGGTCTTTG
 Egr-1Sense AGGACAGGAGGAGGAGATGG62
Antisense GGAAGTGGGCAGAAAGGATTG
shRNA interference
 Con shRNA AATTCTCCGAACGTGTCACGT
 Egr-1 shRNA AAGTTACTACCTCTTATCCAT
Hoechst 33342 (HO)/propidium iodide (PI) staining and ROS staining

To determine the cell death mode, Hoechst 33342 (HO) and propidium iodide (PI) double staining was performed (21,22). In 2D culture, cells were seeded at a density of 2.5×105 cells/ml in 35-mm dishes. After 24 h, the cells were treated with GD for the indicated times and then stained with HO (1 μg/ml) and PI (5 μg/ml) for 15 min. In 3D culture, equal numbers of spheroids were transferred to 1.2% agarose-coated 60-mm dishes and trypsinized and then stained with HO/PI, The stained cells were observed under a fluorescence microscope and apoptotic and necrotic cells were scored. Intracellular H2O2, O2- and mitochondrial ROS measurement were conducted as described previously (21,22).

Egr-1 transfection and short hairpin RNA (shRNA) interference

pcDNA3.1-Egr-1, constructed by inserting the Egr-1 open reading frame into plasmid pcDNA3.1/NEO expression vector (Invitrogen), was provided by Dr Thomas E. Eling (Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, USA). The vectors pcDNA3.1 and pcDNA3.1-Egr-1 were transfected into MCF-7 cells using jetPEI (Polyplus transfection) according to manufacturer’s protocol. Egr-1 shRNA target sequences were designed and verified as specific for Egr-1 by Blast search against the human genome and real-time PCR, respectively (Table I). The vectors pSUPER-control shRNA and pSUPER-Egr-1 shRNA were transfected using jetPEI and stable cell lines were selected using 1–2 mg/ml G418. Several stable clones were isolated after shRNA transfection and individually characterized.

Statistical analysis

Data were analyzed by the Student’s t-test and P<0.05 was considered statistically significant.

Results and Discussion

Induction of Egr-1 by metabolic stress and ROS

We analyzed the gene expression profiling of A549 cells that were treated with GD or GD+PMA by cDNA microarrays (21). One of GD-induced genes was Egr-1 (Fig. 1A); Egr-1 level was increased 3.4-fold during necrosis, whereas its level was not significantly changed during apoptosis. The induction of Egr-1 by GD was also observed in MDA-MB-231 and HepG2 cells that underwent necrosis upon GD, as revealed by RT-PCR (Fig. 1B). We further examined GD induction of Egr-1 in other cancer cells. Western blot analysis showed the induction of Egr-1 by GD in MDA-MB-231 and HepG2 cells, but not in MCF-7 cells that exhibit necrosis to a much lower degree than MDA-MB-231 and HepG2 cells upon GD and in HCT116 and HeLa cells that exhibit apoptosis upon exposure to GD (Fig. 1C). Real-time PCR confirmed the induction of Egr-1 by GD in MDA-MB-231 and HepG2 cells (3- to 4-fold), and but not in MCF-7, HCT116, and HeLa cells (Fig. 1D). GD is known to induce necrosis by increasing mitochondrial ROS production. Thus, we examined the possible role(s) of ROS in GD-induced Egr-1 expression. Egr-1 induction by GD was inhibited by treatment with the antioxidant N-acetylcysteine (NAC) in MDA-MB-231 and HepG2 cells (Fig. 1D). In addition, H2O2 and menadione (an O2- generator) increased Egr-1 mRNA expression in MCF-7 cells as determined by real-time PCR (Fig. 1E), indicating the redox-sensitivity of Egr-1 expression. H2O2 at non-toxic doses has been shown to induce the accumulation of mRNA for Egr-1 gene in mammalian cells (24).

Figure 1

Induction of Egr-1 during GD-induced necrosis. (A) A549 cells were pretreated with PMA and treated with GD for 12 h and microarray analysis was performed. The numbers mean fold increase in expression as compared with GD-untreated control cells. (B) MDA-MB-231 and HepG2 cells were exposed to GD medium for the indicated times, and then analyzed by RT-PCR for Egr-1 and GAPDH. (C) Several cancer cells including MDA-MB-231, HepG2, MCF-7, HCT116, and HeLa were exposed to GD for the indicated times, and then analyzed by western blotting for Egr-1 and α-tubulin. (D) Cancer cells were pretreated with NAC (10 mM) for 1 h, exposed to GD medium for 12 h, and then analyzed by real-time PCR for Egr-1 and β-actin. Results are expressed as mean ± SE. **P<0.01 versus untreated; ##P<0.01 versus GD-treated cells. (E) MCF-7 cells were treated with H2O2 (300 μM) or menadione (O2-, 10 μM) for the indicated times and then analyzed by real-time PCR for Egr-1 and β-actin. Results are expressed as mean ± SE. *P<0.05, **P<0.01 versus untreated.

Egr-1 shRNA prevented metabolic stress-induced necrosis and HMGB1 release

To explore the role(s) of Egr-1 in necrosis, we examined the effects of Egr-1 shRNA, directed to the C-terminal region of human Egr-1 mRNA sequences (position from 1630 to 1648 in human cDNA, Table I), on GD-induced necrosis. HO/PI double staining method was used to identify apoptosis as well as necrosis. While HO penetrates non-selectively plasma membrane of both damaged and intact cells and binds to DNA, causing a blue nuclear fluorescence, PI penetrates only cells with damaged-membranes, causing red nuclear fluorescence. Thus, the cell death mode could be discriminated morphologically by nuclear fluorescence images: intact blue nuclei, condensed/fragmented blue nuclei, condensed/fragmented pink nuclei, and intact pink nuclei indicated viable, early apoptotic, late apoptotic (secondary necrotic), and necrotic cells, respectively. Egr-1 shRNA appeared to effectively knock down Egr-1 mRNA levels in MDA-MB-231 cells, as determined by RT-PCR (Fig. 2A). Egr-1 shRNA significantly inhibited GD-induced cell rounding (data not shown) and increase in cell population that had intact pink nuclei in HO/PI staining in MDA-MB-231 cells (Fig. 2B), without increasing the population of the cells with condensed/fragmented blue nuclei and apoptotic bodies (data not shown). Thus, knockdown of Egr-1 appeared to inhibit GD-induced necrosis without switching to apoptotic cell death as an alternative death mechanism. We also observed that Egr-1 shRNA suppressed GD-induced release of HMGB1 into the extracellular space (Fig. 2C). Previously, we showed that in contrast to a general concept that necrotic cell death causes the release of most cellular proteins due to cell membrane rupture, only a restricted set of cellular proteins such as HMGB1 and CuZnSOD were selectively released during GD-induced necrosis (25). Egr-1 shRNA appeared to suppress GD-induced release of CuZnSOD into the extracellular space (Fig. 2C). These results indicate that Egr-1 may be involved in metabolic stress-induced necrosis.

Figure 2

Egr-1 plays a role(s) in GD-induced necrosis. (A) MDA-MB-231 cells were stably transfected with control or Egr-1 shRNA and exposed to GD for 12 h and then analyzed by RT-PCR using primers for Egr-1. (B) MDA-MB-231 cells stably transfected with control or Egr-1 shRNA were exposed to GD for the indicated times, and stained with HO/PI, and observed by fluorescence microscopy, and apoptotic and necrotic cells were scored. Results are expressed as mean ± SE from 500 to 800 cells per treatment group and from three independent experiments. **P<0.01 versus control; #P<0.05, ##P<0.01 versus control shRNA. (C) MDA-MB-231 cells stably transfected with control or Egr-1 shRNA were exposed to GD for 12 h and the media were analyzed by western blotting with antibodies against HMGB1, CuZnSOD, ERK, and α-tubulin. (D) MDA-MB-231 cells stably transfected with control or Egr-1 shRNA were exposed to GD for 3 or 6 h, and mitochondrial ROS and O2- and intracellular H2O2 production was measured using the MitoTracker Red CM-H2XRos, DHE, and DCFH-DA, respectively, under a fluorescent microscope (X200, Carl Zeiss). Results are expressed as mean ± SE. *P<0.05, **P<0.01 versus untreated; #P<0.05, ##P<0.01 versus control shRNA.

Mitochondrial O2- is induced upon GD and mediates GD-induced necrosis and cytotoxicity (26–28). As shown in Fig. 2D, GD significantly enhanced the production of mitochondrial ROS, O2-, and intracellular H2O2, as revealed by staining with three different fluorogenic probes including MitoTracker Red CM-H2XRos, HE, and DCFH-DA, respectively. Egr-1 interference blocked GD-induced production of mitochondrial ROS, O2-, and intracellular H2O2 (Fig. 2D), indicating that Egr-1 may control necrosis through regulating GD-induced mitochondrial ROS production.

Egr-1 overexpression facilitates GD-induced necrosis

To further examine the role of Egr-1 in necrosis, we overexpressed Egr-1 in MCF-7 cells. Egr-1 is involved in HGF-induced cell scattering, migration, and invasion via Snail activation (19). Egr-1 overexpression in MCF-7 cells caused the morphological changes including loss of intercellular adhesion and formation of a spindle-like cell shape and pseudopodia, which represent the morphology typical of mesenchymal cells (Fig. 3A and B). However, it did not induce necrosis (data not shown). These results demonstrate that Egr-1 is necessary but not sufficient to trigger necrosis. Necrosis is closely linked to excess ROS production, mitochondrial dysfunction, and decreased ATP production (29,30). Thus, Egr-1 may trigger necrosis if tumour cells are under metabolic stress. Therefore, we examined whether Egr-1 overexpression could facilitate GD-inducible necrosis in MCF-7 cells that exhibit a much lower degree (approximately 2–3%) of necrosis upon GD. In MCF-7 cells, Egr-1 overexpression slightly, but to a statistically significant extent (12–13%), increased necrosis upon GD (Fig. 3C), indicating the necrosis-facilitating activity of Egr-1.

Figure 3

Egr-1 overexpression triggers GD-induced necrosis in MCF-7. (A and B) MCF-7 cells were transiently transfected with a pcDNA3.1-Egr-1 expression vector for 48 h and Egr-1 expression was analyzed using RT-PCR and real-time PCR (n=3) for Egr-1 (A) and the cell morphology was examined using phase-contrast microscopy and photographed under magnification ×100–400 (B). (C) MCF-7 cells transiently transfected with pcDNA3.1-Egr-1 plasmid for 5 days were exposed to GD for 12 and 18 h and then stained with HO/PI and observed under a fluorescence microscope and apoptotic and necrotic cells were scored. Results are expressed as mean ± SE from 500 to 800 cells per treatment group and from three independent experiments. Results are expressed as mean ± SE. **P<0.01 versus Mock.

Egr-1 shRNA prevents metabolic stress-induced necrosis in MTSs and suppresses MTS growth

We examined the effects of Egr-1 shRNA on necrosis using MTSs. MTSs closely resemble poorly vascularized solid tumours, and thus are used for an in vitro model of solid tumours. MCF-7 cells formed tightly packed spheroids of a homogeneous size and as the MCF-7 MTSs grow, a proliferation gradient is observed, with proliferating cells at the periphery, cell cycle arrested cells in the inner regions, and necrotizing cells in the core regions (31,32). Continued MTS growth leads to the formation of necrotic core due to microenvironmental stresses including deprivation of oxygen and nutrients. H&E and HO/PI double staining revealed the necrotic core formation at 8–9 days of MTS culture (22,33). Although monolayer-cultured MCF-7 cells exhibit limited levels of necrosis upon GD, they showed prominent necrotic cell death in the core region when cultured as MTSs. An increased expression of Egr-1 was detected with extended MTS culture (Fig. 4A); Egr-1 induction was observed at 7 and 9 day MTSs. To determine the expression of Egr-1 in MTSs, the spheroids were selectively dissociated to yield cells from four discrete regions within the spheroid. Enhanced Egr-1 expression was detected in the innermost F4 fraction (Fig. 4B), indicating that Egr-1 expression is closely related to microenvironmental stresses, such as hypoxia and GD. As shown in Fig. 4C, Egr-1 shRNA prevented MTS growth. We further found that Egr-1 shRNA caused a prominent reduction in the population of cells that had pink nuclei with HO/PI staining at 9 days in MCF-7 MTS culture (Fig. 4D). These findings demonstrate that Egr-1 is involved in GD-induced necrosis and tumour progression.

Figure 4

Egr-1 shRNA inhibits the growth of multicellular tumour spheroids (MTSs). (A) MCF-7 spheroids were seeded into 1.2% agarose-coated 96-well plates at a density of 400 cells per well and cultured for up to 9 days. The MTS was analyzed by real-time PCR for Egr-1 expression. The values are expressed as mean ± SE (n=3). *P<0.05, **P<0.01 versus two-dimensional cultured cells. (B) After 7 days of MCF-7 MTS culture, the MTSs were dissociated into subpopulations of cells from different locations in the spheroids, as described in Materials and methods. The isolated cells were analyzed by RT-PCR using primers for Egr-1 and GAPDH. (C) MTS of MCF-7 cells stably transfected with control or Egr-1 shRNA were cultured for up to 9 days. To calculate MTS size, diameters of five spheroids were measured every day. Results are expressed as mean ± SE. **P<0.01 versus control shRNA. (D) MTS of MCF-7 cells stably transfected with control or Egr-1 shRNA were cultured for 7 and 9 days and the cells were isolated and stained with HO/PI and apoptotic and necrotic cells were scored. Results are expressed as mean ± SE from 500 to 800 cells per treatment group and from three independent experiments. Results are expressed as mean ± SE. **P<0.01 versus 7 days MTS; **P<0.01 versus control shRNA.

Biological relevance of this study

An immediate early gene Egr-1 is implicated in tumour cell biology. While Egr-1 is known to induce apoptosis in tumour cells, it also promotes tumour progression, survival, and angiogenesis (6–13). In this study, we showed that Egr-1 is induced upon GD and is implicated in GD-induced necrosis. Egr-1 appeared to be induced by GD-triggered mitochondrial ROS production and to exert a positive effect on mitochondrial ROS production, in a forward feeding ROS-producing fashion. ROS induced under stressful conditions are known to move from a mitochondrion to neighboring mitochondria to enhance ROS production in a process known as ROS-induced ROS release (RIRR) (34,35). Thus, Egr-1 may be implicated in the mechanisms for RIRR, which is responsible for GD-induced necrosis. How does Egr-1 affect mitochondrial ROS production upon GD? Mitochondrial dysfunction has been shown to be linked to increased ROS production and necrosis induction. For instance, tumour cells with dysregulated mitochondria undergo necrosis in response to a glycolysis inhibitor 2-deoxyglucose or alkylating DNA damage that causes rapid ATP depletion (36). Thus, Egr-1 may regulate genes linked to mitochondrial dysfunction. Previously, we showed that Snail (22) and Dlx-2 (37) are also implicated in GD-induced necrosis; thus, Snail, Dlx-2 and Egr-1 may cooperate to induce necrosis. We further showed that Snail suppressed mitochondrial respiration and cytochrome C oxidase (COX) activity by inhibiting the expression of 3 COX subunits, including COXVIc, COXVIIa, and COXVIIc (38). Because Egr-1 is able to induce Snail (data not shown), Snail may be responsible for Egr-1-triggered necrosis. The mechanism whereby Egr-1 and Snail enhance mitochondrial depression, mitochondrial ROS production, and necrosis is under investigation.

Acknowledgements

This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2009-0072912). We thank Dr Thomas E. Eling (Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, USA) and Dr J.I. Yook (University of Yonsei, Korea) for providing pcDNA3.1-Egr-1 and MCF-7 cells, respectively.

References

1 

Vakkila J and Lotze MT: Inflammation and necrosis promote tumour growth. Nat Rev Immunol. 4:641–648. 2004. View Article : Google Scholar : PubMed/NCBI

2 

Jin S and White E: Role of autophagy in cancer: management of metabolic stress. Autophagy. 3:28–31. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 5:331–342. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Schlueter C, Weber H, Meyer B, Rogalla P, Roser K, Hauke S and Bullerdiek J: Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol. 166:1259–1263. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004. View Article : Google Scholar : PubMed/NCBI

6 

Adamson ED and Mercola D: Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumour Biol. 23:93–102. 2002. View Article : Google Scholar : PubMed/NCBI

7 

Thiel G and Cibelli G: Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol. 193:287–292. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Xie B, Wang C, Zheng Z, Song B, Ma C, Thiel G and Li M: Egr-1 transactivates Bim gene expression to promote neuronal apoptosis. J Neurosci. 31:5032–5044. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Yamaguchi H, Chen CT, Chou CK, Pal A, Bornmann W, Hortobagyi GN and Hung MC: Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation. Oncogene. 29:5619–5629. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Mahalingam D, Natoni A, Keane M, Samali A and Szegezdi E: Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells. Br J Cancer. 102:754–764. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Wagner M, Schmelz K, Dorken B and Tamm I: Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factor. Int J Cancer. 122:1278–1287. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Zagurovskaya M, Shareef MM, Das A, Reeves A, Gupta S, Sudol M, Bedford MT, Prichard J, Mohiuddin M and Ahmed MM: EGR-1 forms a complex with YAP-1 and upregulates Bax expresion in irradiated prostate carcinoma cells. Oncogene. 28:1121–1131. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Ahmed MM: Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors. Curr Cancer Drug Targets. 4:43–52. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Baron V, Adamson ED, Calogero A, Ragona G and Mercola D: The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther. 13:115–124. 2006. View Article : Google Scholar : PubMed/NCBI

15 

Rong Y, Hu F, Huang R, Mackman N, Horowitz JM, Jensen RL, Durden DL, Van Meir EG and Brat DJ: Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res. 66:7067–7074. 2006. View Article : Google Scholar

16 

Liao H, Hyman MC, Lawrence DA and Pinsky DJ: Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J. 21:935–949. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Zhang P, Tchou-Wong KM and Costa M: Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res. 67:9125–9133. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Nishi H, Nishi KH and Johnson AC: Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res. 62:827–834. 2002.PubMed/NCBI

19 

Grotegut S, von Schweinitz D, Christofori G and Lehembre F: Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 25:3534–3545. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Lucerna M, Pomyje J, Mechtcheriakova D, Kadl A, Gruber F, Bilban M, Sobanov Y, Schabbauer G, Breuss J, Wagner O, Bischoff M, Clauss M, Binder BR and Hofer E: Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. Cancer Res. 66:6708–6713. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Kim CH, Han SI, Lee SY, Youk HS, Moon JY, Duong HQ, Park MJ, Joo YM, Park HG, Kim YJ, Yoo MA, Lim SC and Kang HS: Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells. J Cell Physiol. 211:371–385. 2007. View Article : Google Scholar

22 

Kim CH, Jeon HM, Lee SY, Ju MK, Moon JY, Park HG, Yoo MA, Choi BT, Yook JI, Lim SC, Han SI and Kang HS: Implication of snail in metabolic stress-induced necrosis. PLoS One. 6:e180002011. View Article : Google Scholar : PubMed/NCBI

23 

LaRue KE, Khalil M and Freyer JP: Microenvironmental regulation of proliferation in multicellular spheroids is mediated through differential expression of cyclin-dependent kinase inhibitors. Cancer Res. 64:1621–1631. 2004. View Article : Google Scholar

24 

Nose K and Ohba M: Functional activation of the egr-1 (early growth response-1) gene by hydrogen peroxide. Biochem J. 316:381–383. 1996.PubMed/NCBI

25 

Han SI, Duong HQ, Choi JE, Lee TB, Kim CH, Lee SY, Jeon HM, Shin SH, Lim SC and Kang HS: Hyperthermia switches glucose depletion-induced necrosis to apoptosis in A549 lung adenocarcinoma cells. Int J Oncol. 32:851–860. 2008.PubMed/NCBI

26 

Ahmad IM, Aykin-Burns N, Sim JE, Walsh SA, Higashikubo R, Buettner GR, Venkataraman S, Mackey MA, Flanagan SW, Oberley LW and Spitz DR: Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. J Biol Chem. 280:4254–4263. 2005.PubMed/NCBI

27 

Spitz DR, Sim JE, Ridnour LA, Galoforo SS and Lee YJ: Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann NY Acad Sci. 899:349–362. 2000. View Article : Google Scholar

28 

Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW and Spitz DR: Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J. 418:29–37. 2009.

29 

Zong WX and Thompson CB: Necrotic death as a cell fate. Genes Dev. 20:1–15. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Golstein P and Kroemer G: Cell death by necrosis: towards a molecular definition. Trends Biochem Sci. 32:37–43. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Panda AK and Labhasetwar V: 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm. 5:849–862. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Ivascu A and Kubbies M: Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol. 31:1403–1413. 2007.PubMed/NCBI

33 

Jeong EK, Lee SY, Jeon HM, Ju MK, Kim CH and Kang HS: Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells. Int J Oncol. 37:655–661. 2010.PubMed/NCBI

34 

Zorov DB, Filburn CR, Klotz LO, Zweier JL and Sollott SJ: Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 192:1001–1014. 2000. View Article : Google Scholar

35 

Zorov DB, Juhaszova M and Sollott SJ: Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta. 1757:509–517. 2006. View Article : Google Scholar : PubMed/NCBI

36 

Zong WX, Ditsworth D, Bauer DE, Wang ZQ and Thompson CB: Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18:1272–1282. 2004. View Article : Google Scholar : PubMed/NCBI

37 

Lee SY, Jeon HM, Kim CH, Ju MK, Bae HS, Park HG, Lim SC, Han SI and Kang HS: Homeobox gene Dlx-2 is implicated in metabolic stress-induced necrosis. Mol Cancer. 10:1132011. View Article : Google Scholar : PubMed/NCBI

38 

Lee SY, Jeon HM, Ju MK, Kim CH, Yoon G, Han SI, Park HG and Kang HS: Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism. Cancer Res. 72:3607–3617. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jeon HM, Lee SY, Ju MK, Kim CH, Park HG and Kang HS: Early growth response 1 regulates glucose deprivation-induced necrosis. Oncol Rep 29: 669-675, 2013.
APA
Jeon, H.M., Lee, S.Y., Ju, M.K., Kim, C.H., Park, H.G., & Kang, H.S. (2013). Early growth response 1 regulates glucose deprivation-induced necrosis. Oncology Reports, 29, 669-675. https://doi.org/10.3892/or.2012.2134
MLA
Jeon, H. M., Lee, S. Y., Ju, M. K., Kim, C. H., Park, H. G., Kang, H. S."Early growth response 1 regulates glucose deprivation-induced necrosis". Oncology Reports 29.2 (2013): 669-675.
Chicago
Jeon, H. M., Lee, S. Y., Ju, M. K., Kim, C. H., Park, H. G., Kang, H. S."Early growth response 1 regulates glucose deprivation-induced necrosis". Oncology Reports 29, no. 2 (2013): 669-675. https://doi.org/10.3892/or.2012.2134
Copy and paste a formatted citation
x
Spandidos Publications style
Jeon HM, Lee SY, Ju MK, Kim CH, Park HG and Kang HS: Early growth response 1 regulates glucose deprivation-induced necrosis. Oncol Rep 29: 669-675, 2013.
APA
Jeon, H.M., Lee, S.Y., Ju, M.K., Kim, C.H., Park, H.G., & Kang, H.S. (2013). Early growth response 1 regulates glucose deprivation-induced necrosis. Oncology Reports, 29, 669-675. https://doi.org/10.3892/or.2012.2134
MLA
Jeon, H. M., Lee, S. Y., Ju, M. K., Kim, C. H., Park, H. G., Kang, H. S."Early growth response 1 regulates glucose deprivation-induced necrosis". Oncology Reports 29.2 (2013): 669-675.
Chicago
Jeon, H. M., Lee, S. Y., Ju, M. K., Kim, C. H., Park, H. G., Kang, H. S."Early growth response 1 regulates glucose deprivation-induced necrosis". Oncology Reports 29, no. 2 (2013): 669-675. https://doi.org/10.3892/or.2012.2134
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team